Important Safety Information for Mounjaro® (tirzepatide) Injection

Warning: Risk of Thyroid C-Cell Tumors
Mounjaro® (tirzepatide) injection may cause thyroid tumors, including thyroid cancer. Watch for symptoms such as a lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath. If you experience any of these symptoms, inform your healthcare provider immediately.

• Do not use Mounjaro® (tirzepatide) injection if you or any family members have a history of medullary thyroid carcinoma (MTC).
• Do not use if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is the FDA-approved use of Mounjaro® (tirzepatide) injection?

Mounjaro® (tirzepatide) is an injectable medication approved for adults with type 2 diabetes. It is used alongside diet and exercise to improve blood sugar (glucose) control.

Limitations of Use:

• It is not known if Mounjaro® can be used in people with a history of pancreatitis.
• It is not approved for type 1 diabetes or for use in children under 18 years of age.

Who should not use Mounjaro® (tirzepatide) injection?

Do not use Mounjaro® if:

• You or a family member has a history of medullary thyroid carcinoma (MTC) or MEN 2.
• You are allergic to Mounjaro® or its ingredients.

How should I take Mounjaro® (tirzepatide) injection?

• Take Mounjaro® once weekly, on the same day each week, with or without food.
• Use the pre-filled injector pen as a subcutaneous injection in your stomach, thigh, or upper arm. Rotate injection sites weekly.
• Follow the dosing regimen provided by your WeightMeds provider, which may include dose increases every four weeks.

Do not change or stop your prescribed regimen without consulting your WeightMeds provider. If you take too much Mounjaro®, contact your healthcare provider immediately.

What should I discuss with my WeightMeds provider before starting Mounjaro®?

• Share your full medical history, including any thyroid, gastrointestinal, pancreatic, kidney, or vision issues.
• Discuss all medications, including over-the-counter drugs, supplements, and vitamins, as Mounjaro® may interact with some medications.
• Inform your provider if you are pregnant, planning to become pregnant, or breastfeeding.
• If using oral birth control, switch to a non-oral method or use a barrier method for 4 weeks after starting or increasing your dose of Mounjaro®.

Most Serious Side Effects to Monitor For:

• Thyroid C-Cell Tumors
• Severe Gastrointestinal Issues: Nausea, vomiting, or diarrhea that may worsen pre-existing conditions.
• Pancreatitis: Severe abdominal pain that may radiate to the back.
• Low Blood Sugar (Hypoglycemia): Symptoms include dizziness, sweating, confusion, or rapid heartbeat.
• Allergic Reactions: Swelling, rash, or difficulty breathing.
• Kidney Problems: Dehydration may worsen kidney function.
• Gallbladder Issues: Look for abdominal pain, fever, jaundice, or unusual stools.
• Vision Changes: Particularly if you have diabetic retinopathy.
• Mental Health Changes: Report any suicidal thoughts or mood changes immediately.

Common Side Effects:

• Nausea, vomiting, or diarrhea
• Constipation or indigestion
• Injection site reactions
• Tiredness
• Belching or heartburn

For a full list of side effects and complete safety information, consult the prescribing information.

Disclaimer:
WeightMeds has no affiliation with Novo Nordisk, Eli Lilly, or Amylin Pharmaceuticals. Medications offered by WeightMeds are not manufactured by these companies. Trademarks such as Ozempic®, Wegovy®, and Mounjaro® are owned by their respective manufacturers.

For more information, contact WeightMeds or your healthcare provider.